Clinical trial · Interventional
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity: a Randomized Multicenter Clinical Trial
NCT04500392CI-TRIAL-00072906unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Hypoxia is the most common adverse event during gastrointestinal endoscopes sedated with propofol and sufentanil, especially in obese people. In the present study, high-flow nasal cannula oxygenation will be utilized in order to reduce the incidence of hypoxia among obesity.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
| Esophagus Cancer | — | UNRESOLVED | — |
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
| Hypoxia | — | UNRESOLVED | — |
| Polyp of Colon | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| High-flow nasal cannula oxygenation | Device | — | UNRESOLVED |
| Regular nasal cannula | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Control group
- description
- Oxygen(up to 6L/min) supplied with a regular nasal catheter
- interventionNames
- Device: Regular nasal cannula
- type
- EXPERIMENTAL
- label
- High-flow nasal cannula group
- description
- Oxygen(up to 60L/min) supplied with high-flow nasal cannula
- interventionNames
- Device: High-flow nasal cannula oxygenation
Primary outcomes (1)
- measure
- The incidence of hypoxia
- timeFrame
- Patients will be followed for the duration of hospital stay, an expected average of 2 hours]
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * patients undergoing gastrointestinal endoscopes * age≥18 years old and ≤70 years old * patients or family members signed informed consent form * ASA classification I-II * BMI≥ 28kg/m² Exclusion Criteria: * Coagulation disorders or a tendency of nose bleeding; * An episode/exacerbation of congestive heart failure (CHF) that requires a change in medication, diet or hospitalization from any cause in the last 6 months; * Severe aortic stenosis or mitral stenosis; * Cardiac surgery involving thoracotomy (e.g., coronary artery bypass graft (CABG), valve replacement surgery) in the last 6 months; * Acute myocardial infarction in the last 6 months; * Acute arrhythmia (including any tachycardia - or bradycardia) with the fluid of hemodynamics instability; * Diagnosed chronic obstructive pulmonary disease or current other acute or chronic lung disease requiring supplemental chronic or intermittent oxygen therapy); * Increased intracranial pressure; * ASA classification Ⅲ-Ⅳ ; * Mouth, nose, or throat infection; * Liver and kidney disease * Fever, defined as core body temperature \> 37.5℃; * Pregnancy, breastfeeding or positive pregnancy test; * Emergency procedure; * Patients or family members refused to participate * Mental disorders and people without civil capacity
References
Publications (1)
- DERIVEDWang L, Zhang Y, Han D, Wei M, Zhang J, Cheng X, Zhang Y, Shi M, Song Z, Wang X, Zhang X, Su D. Effect of high flow nasal cannula oxygenation on incidence of hypoxia during sedated gastrointestinal endoscopy in patients with obesity: multicentre randomised controlled trial. BMJ. 2025 Feb 11;388:e080795. doi: 10.1136/bmj-2024-080795. PMID 39933757